SUMMARY Pancreatic exocrine function tests and plasma insulin curves after a glucose load have been performed in 74 patients, 32 with no significant pancreatic disease, 31 with various disorders of the pancreas, and 11 with postmature diabetes mellitus.
The value of tests of pancreatic exocrine function is well established (Burton, Evans, Harper, Howat, Oleesky, Scott, and Varley, 1960) . Less is known about the changes which occur in plasma insulin levels in diseases of the pancreas. Peters, Dick, Hales, Orrell, and Sarner (1966) , in a small series of cases, found that their patients with chronic pancreatitis showed an inadequate production of insulin, as compared with the normal, and were all mildly diabetic.
The patients with postmature diabetes mellitus, who showed greater abnormalities of glucose tolerance, had mean plasma insulin concentrations greater than the patients with chronic pancreatitis both after fasting and following oral glucose. It has been suggested that the mild diabetes of chronic pancreatitis differs from the ordinary type of diabetes in the infrequency of renal and vascular complications and the rarity of ketosis. A different mechanism of production of the diabetic state might be reflected in a different response of insulin production to a glucose load. Linquette, Fossati, Fourlinnie, and
Received for publication 21 May 1969. Paris (1968) examined the plasma insulin response to a glucose load in 28 patients with chronic pancreatitis and demonstrated impaired insulin production in a proportion of their cases. Joffe, Bank, Jackson, Keller, O'Reilly, and Vinik (1968) approached the matter from a different aspect, testing the plasma insulin levels following a glucose load, the pancreas being stimulated with intravenous tolbutamide and glucagon half an hour after the glucose had been given. Using this method of islet cell stimulation they found low responses in all their patients with chronic pancreatitis. Ohlsen (1968) has examined the insulin production in response to glucose infusion in 20 out of 27 patients with chronic pancreatitis, who had not previously been treated with insulin. He found a decreased initial insulin response in all of those with overt diabetes who could be tested.
Plasma insulin curves following a glucose load have now been performed in a series of 74 patients in whom pancreatic function was being studied. The method used has been previously described (Peters et al, 1966) and follows, with minor modifications, the technique of Burton et al (1960) . Pancreatic juice was collected over two 10-minute control periods, three 10-minute periods after secretin injections, and three 10-minute periods after pancreozymin injection. The volume of juice, the bicarbonate concentration, and the amylase content only were estimated in view of the finding of Burton et al (1960) that no advantage was gained from the simultaneous estimation of trypsin and lipase. The criteria of normality used in analysing our results for this test followed those described by Burton et al (1960) .
ENDOCRINE FUNCTION
A standard two-hour oral glucose tolerance test was carried out, the dose of glucose being 50 g. Blood glucose was estimated by the glucose oxidase method on the Technicon AutoAnalyzer (Wincey and Marks, 1961) . This was considered to be abnormal, in accordance with the criteria described by Conn (1958) , when the blood glucose exceeded one of the following levels: 160 mg per 100 ml at one hour, 140 mg per 100 ml at one and a half hours, or 120 mg per 100 ml at two hours.
Plasma insulin concentrations were measured on the same specimens of blood during the twohour oral glucose tolerance test, using the immunoassay described by Hales and Randle (1963 (Table V) . In the case of volume of juice, the sums of the 10-minute collections for the resting, postsecretin, and postpancreozymin periods have been taken separately and the means calculated. For bicarbonate and amylase secretion, the highest concentration occurring during each period has been used. Table VI and Fig. 1 give the results of exocrine pancreatic function tests in the 32 control patients and in the 17 patients with chronic and chronic relapsing pancreatitis.
There was no significant difference in the volume ofjuice in any period of the tests between the control and the pancreatitic patients. No difference was found in the concentration of bicarbonate during the resting period, but the concentration of bicarbonate after both secretin (Figs. 2 and 3 ) and the means and two standard errors in Figure 4 .
Two of the control patients had a flat insulin response curve, but in neither was there any confirmatory evidence of chronic pancreatitis. One patient had a delayed-rise insulin response. The remaining 29 had normal insulin response curves and included the patient mentioned above with impaired exocrine function.
In the chronic relapsing pancreatitis group, the tests of pancreatic function were all carried out more than three months after an acute exacerbation. Of the 17 patients in this and the chronic pancreatitis group, all had abnormal exocrine function. Eight had impaired endocrine function, and of these, seven had a flat insulin response and one a delayed rise curve. With one exception, all these eight patients had a diabetic glucose tolerance curve, and in the exception the result was borderline. Thus all the patients with an abnormal insulin production had abnormal, often markedly so, exocrine function, but the reverse did not apply. The remaining nine patients with chronic pancreatic disease had normal insulin production, but in one of these the glucose tolerance test gave a diabetic curve in spite of the normal insulin response. Thus, of the 10 patients with chronic pancreatitis who were not subject to exacerbations, seven had an abnormal insulin response, whereas of the seven with chronic relapsing pancreatitis only one had an abnormal insulin curve. This difference is striking. Only two patients with haemochromatosis were studied. In both there was definite histological evidence of the diagnosis on liver biopsy, and both had an abnormally high serum iron-binding capacity. The exocrine pancreatic function test in one of these was abnormal, showing an increased postsecretin volume of juice and a reduced concentration of bicarbonate and amylase throughout. In this patient the plasma insulin curve was normal. The other patient had normal exocrine pancreatic function, but his insulin response curve was flat. This patient had a diabetic glucose tolerance test and was currently being treated with chlorpropamide.
FIBROCYSTIC DISEASE
Only one patient with fibrocystic disease was examined. He was a boy of 16 who had abnormal exocrine function, a delayed rise in the plasma insulin curve, but a normal glucose tolerance test.
DIABETES MELLITUS
The findings in the 11 patients finally placed in the diabetes mellitus group are shown in Table  VIII . In fact, of the 11 patients originally presenting with diabetes, four had a flat insulin curve. One of these subsequently developed frank steatorrhoea, and another was found to have a raised fat content in the stools, both showing impaired exocrine function on testing. As mentioned above, these two cases were regarded as having chronic pancreatitis. The other two patients in this group with a flat insulin response have shown no evidence of diffuse pancreatic disease to the present time. The individual insulin curves of the patients with diabetes mellitus are shown in a scattergram (Fig. 5) It is considered that the criterion of the flat insulin response, defined above, enables cases with reduced insulin production to be separated clearly from those with normal insulin output.
Only one out of seven cases of chronic relapsing pancreatitis showed impaired insulin production, as compared with seven out of 10 patients with chronic pancreatitis without exacerbation. There is no reason to believe that these two conditions are fundamentally different. In our small series, both groups contained alcoholic patients and pancreatic calcification occurred in some instances. It may be that in the cases of chronic pancreatitis without exacerbation, half of whom had no pain, the disease process had been present for some years, before presenting, for example, with steatorrhoea. The mode of presentation in chronic relapsing pancreatitis with severe pain leads to earlier diagnosis, and it may be that many of the islet cells at this stage are still undamaged. The only patient with chronic relapsing pancreatitis who had endocrine impairment had a six-year history of attacks, and was indeed the only patient with chronic relapsing pancreatitis to have frank steatorrhoea, although all the cases had abnormal exocrine function.
How often a flat insulin response curve may be the first indication of diffuse pancreatic disease is not known, but it seems likely that this may occur on occasion. Of four patients presenting with diabetes mellitus and found to have flat insulin curves, two showed evidence of pancreatic insufficiency on further investigation. One of the patients with a carcinoma of the pancreas had a flat insulin curve at a time when his faecal fat and exocrine function were normal.
The postmature diabetic patient, as a general rule, has a normal or raised fasting plasma insulin but often shows a delayed rise after glucose, the curve then remaining high and not returning to the fasting level within two hours. When a flat insulin response is found in an apparently straightforward case of postmature diabetes, what is the explanation? It would at any rate appear that it is worth investigating such cases for evidence of chronic pancreatitis or possibly a neoplasm. Whether there is a group of ordinary postmature diabetics in whom the insulin curve is flat remains to be elucidated.
Patients with chronic pancreatitis and relatively severe insulin deficiency often show less loss of glucose tolerance than patients with postmature diabetes mellitus. In chronic pancreatitis, a loss of pancreatic islet alpha cell function and glucagon production may partially compensate for insulin deficiency.
Plasma insulin curves may contribute substantially to the investigation of individual cases of pancreatic disease. A low insulin output supports the diagnosis of diffuse pancreatic disease and its finding may indicate damage of some severity. It may prove to be of value in the early diagnosis of carcinoma of the pancreas. Conversely, in a patient presenting with diabetes mellitus, in whom any suspicion of chronic pancreatitis or a neoplasm arises, a low insulin response curve is an indication for further investigation.
